Related Experiment Video
Updated: Jun 17, 2026
12:56
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
Published on: December 19, 2017
7.8K
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.
Lorenzo Caruso1, Matteo Fields2, Erika Rimondi3
1Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.
International Journal of Molecular Sciences
|February 24, 2024
Summary
New research explores therapeutic strategies for retinopathies, focusing on mesenchymal stem cell secretomes, noncoding RNAs, and the gut-eye axis. Retinal organoids offer a promising model for studying these complex eye diseases.
Area of Science:
- Ophthalmology and Regenerative Medicine
- Cell Biology and Molecular Mechanisms of Disease
Background:
- Retinopathies stem from inflammation, oxidative stress, and impaired apoptosis/autophagy in retinal cells, lacking regenerative capacity.
- Emerging research highlights the therapeutic potential of mesenchymal stem cell secretomes and noncoding RNAs (ncRNAs) in treating retinopathies.
- The gut-eye axis, linking gut microbiota alterations to ocular diseases, presents a novel area for investigation.
Purpose of the Study:
- To review current and emerging therapeutic strategies for retinopathies.
- To explore the role of mesenchymal stem cell secretomes, ncRNAs, and the gut-eye axis in retinopathy pathogenesis and treatment.
- To emphasize the utility of retinal organoids as a model for studying retinopathies.
Main Methods:
- Review of experimental data and recent findings on mesenchymal stem cell secretomes.
- Analysis of studies investigating noncoding RNAs (ncRNAs) as therapeutic targets and biomarkers for retinopathies.
- Exploration of research on the gut-eye axis and its implications for ocular diseases.
- Assessment of retinal organoids as a model system for retinopathy research.
Main Results:
- Mesenchymal stem cell secretomes may mitigate oxidative stress, apoptosis, and autophagy in retinal cells.
- Noncoding RNAs (ncRNAs) show promise as therapeutic targets and biomarkers for retinopathies.
- Gut microbiota dysbiosis is increasingly linked to ocular pathologies via the gut-eye axis.
- Retinal organoids effectively model retinal complexity for disease study.
Conclusions:
- Novel therapeutic avenues for retinopathies involve targeting mesenchymal stem cell secretomes, ncRNAs, and the gut-eye axis.
- Retinal organoids provide a valuable platform for advancing the understanding and treatment of retinopathies.
- Integrated approaches considering cellular mechanisms, molecular targets, and systemic interactions are crucial for future retinopathy therapies.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...